Ceryx Medical announced that it closed a new funding round, bringing its total raised to $15 million to support its pacing technology.
The London-based company aims to revolutionise cardiac care through intelligent, adaptive pacing technology....
Ceryx Medical announced that it closed a new funding round, bringing its total raised to $15 million to support its pacing technology.
The London-based company...
Nuclear medical imaging device firm Positrigo of Zurich, Switzerland, has closed a financing round valued at 7 million Swiss francs ($8.5 million U.S.).
With lead...
Creo Medical has achieved a significant milestone with its SpyderBlade Flex surgical device earning clearance from the US Food and Drug Administration (FDA). This...
FineHeart announced French regulators gave it the green light to initiate a first-in-human heart device trial in France.
The French National Agency for the Safety...
NeuroPace announced preliminary one-year results from its Nautilus clinical study evaluating neuromodulation therapy for idiopathic generalised epilepsy (IGE).
The company said the study met its...
Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface technology. The company evaluated the safety and feasibility of...
Ceryx Medical announced that it closed a new funding round, bringing its total raised to $15 million to support its pacing technology.
The London-based company...
Nuclear medical imaging device firm Positrigo of Zurich, Switzerland, has closed a financing round valued at 7 million Swiss francs ($8.5 million U.S.).
With lead...
Creo Medical has achieved a significant milestone with its SpyderBlade Flex surgical device earning clearance from the US Food and Drug Administration (FDA). This...